ValuationViz

DNTH fund manager activity

Dianthus Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2025 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded23,353$2,276,4490.00%Aug 4, 2026
Polen Capital ManagementAdded9,333$909,7810.01%Aug 4, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed12,620$1,059,0690.00%May 5, 2026
Polen Capital ManagementNew4,119$345,6660.00%May 14, 2026

Older quarters